About Us
We embrace the rare
Who We Are
Together for the rare
What We Do
Ensuring Access, Caring for Patients
NewGen Pharma's primary business focus is patient-centered, with a particular emphasis on innovative biotechnological drugs that face access and supply challenges due to the small number of affected patients.
These drugs are typically developed for rare and orphan diseases, and achieving access to treatment can be a significant challenge. The company aims to overcome these supply difficulties and improve patients' lives by developing innovative solutions and global strategies, ensuring broader access to these medications for a larger patient population. NewGen Pharma is committed to putting patient needs at the forefront and providing access to treatment through solutions that transcend the limitations of healthcare systems.
Our Mission
Every rare life matters
At Newgen Pharma, our mission is to ensure broad access to high-quality specialty medicines for the prevention and treatment of rare, complex, and life-threatening diseases, while maintaining affordability. We are committed to bridging innovation with access, working tirelessly with stakeholders across the healthcare ecosystem to ensure that patients receive the treatments they need.
Our Vision
Rare is real. And we care
With deep expertise in regulatory pathways, strategic partnerships, and a patient-centric approach, we collaborate with global pharmaceutical companies to bring innovative and cost-effective therapies to Turkey and the Central & Eastern Europe (CEE) region. Our commitment to compliance, quality, and ethical healthcare solutions drives us to transform lives by making essential treatments both accessible and affordable.
At Newgen Pharma, we believe in "Ensuring Access, Caring for Patients."
